Aptevo Therapeutics

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$3.65-$399.60
Market Cap
$6.6M
Shares Short
241,678

Financials

See more
Revenue (12 Mos)
$0
Revenue Growth (YoY)
-100%
Gross Profit (12 Mos)
$3.1M
Diluted EPS
-$415.99

News

See more

Yahoo Finance • 2 years ago

Aptevo Therapeutics Reports 1Q23 Financial Results and Provides Business Update

Yahoo Finance • 3 years ago

Aptevo Therapeutics Announces New Preliminary Remission Data on Four Additional Patients Enrolled in On-going APVO436 Dose Expansion Phase 1b Trial for the Treatment of Acute Myeloid Leukemia

About

CEO
Mr. Marvin L. White
CFO
Ms. Daphne L. Taylor CPA
Address
2401 4th Avenue, Seattle, WA, United States, 98121
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
40